nat-bendamustine powder for solution
natco pharma (canada) inc - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg - antineoplastic agents
bendamustine hydrochloride for injection powder for solution
jamp pharma corporation - bendamustine hydrochloride - powder for solution - 25mg - bendamustine hydrochloride 25mg - antineoplastic agents
bendamustine hydrochloride for injection powder for solution
jamp pharma corporation - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg - antineoplastic agents
bendamustine hydrochloride for injection powder for solution
auro pharma inc - bendamustine hydrochloride - powder for solution - 25mg - bendamustine hydrochloride 25mg - antineoplastic agents
bendamustine hydrochloride for injection powder for solution
auro pharma inc - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg - antineoplastic agents
bendamustine hydrochloride- bendamustine hydrochloride injection
eagle pharmaceuticals, inc - bendamustine hydrochloride (unii: 981y8sx18m) (bendamustine - unii:9266d9p3pq) - bendamustine hydrochloride injection is indicated for the treatment of patients with chronic lymphocytic leukemia. efficacy relative to first line therapies other than chlorambucil has not been established. bendamustine hydrochloride injection is indicated for the treatment of patients with indolent b-cell non-hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. bendamustine hydrochloride injection is contraindicated in patients with a known hypersensitivity (e.g., anaphylactic and anaphylactoid reactions) to bendamustine, polyethylene glycol 400, propylene glycol, or monothioglycerol. [see warnings and precautions (5.3)] pregnancy category d [see warnings and precautions (5.9)] risk summary bendamustine hydrochloride can cause fetal harm when administered to a pregnant woman. bendamustine caused malformations in animals, when a single dose was administered to pregnant animals. advise women to avoid becoming pregnant while receiving be
bendroflumethiazide 5mg tablets
dowelhurst ltd - bendroflumethiazide - oral tablet - 5mg
bendroflumethiazide 5mg tablets
sovereign medical ltd - bendroflumethiazide - oral tablet - 5mg
bendroflumethiazide 5mg tablets
phoenix healthcare distribution ltd - bendroflumethiazide - oral tablet - 5mg
bendroflumethiazide 5mg tablets
waymade healthcare plc - bendroflumethiazide - oral tablet - 5mg